04/24/2024
7:00 AM | PMV Pharmaceuticals (Filer)
| Form DEF 14A | |
04/24/2024
7:01 AM | PMV Pharmaceuticals (Filer)
| Form DEFA14A | |
04/24/2024
7:02 AM | PMV Pharmaceuticals (Filer)
| Form ARS | |
04/09/2024
12:17 PM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/29/2024
3:05 PM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:05 PM | PMV Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
2:38 PM | ArrowMark Colorado Holdings LLC (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G | |
|
02/14/2024
8:18 AM | Avoro Capital Advisors LLC (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
6:52 AM | PMV Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
01/29/2024
2:26 PM | PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/24/2024
8:01 AM | PMV Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/23/2024
8:07 AM | PMV Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024
8:40 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024
3:02 PM | Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:04 PM | Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:06 PM | Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:18 PM | Carulli Michael (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/24/2023
3:38 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/12/2023
4:02 PM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
3:22 PM | Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:26 PM | Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
7:01 AM | PMV Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/07/2023
3:35 PM | BlackRock Inc. (Filed by)
PMV Pharmaceuticals (Subject)
| Form SC 13G/A | |
06/12/2023
4:39 PM | Heyman Richard A. (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
4:49 PM | LEVINE ARNOLD J (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
4:55 PM | PMV Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:01 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
5:14 PM | Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
5:18 PM | Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
4:48 PM | Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
8:19 AM | PMV Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
05/10/2023
7:00 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
7:02 AM | PMV Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2023
11:15 PM | PMV Pharmaceuticals (Filer)
| Form EFFECT | |
04/28/2023
7:01 AM | PMV Pharmaceuticals (Filer)
| Form DEF 14A | |
04/28/2023
7:01 AM | PMV Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
7:03 AM | PMV Pharmaceuticals (Filer)
| Form DEFA14A | |
04/28/2023
7:04 AM | PMV Pharmaceuticals (Filer)
| Form ARS | |
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide |
